S&P downgrades Hologic (HOLX) from BB+ to BB; outlook Negative
Tweet
Share
E-mailGet Alerts HOLX Hot Sheet
Join SI Premium – FREE
S&P downgrades Hologic (Nasdaq: HOLX) from BB+ to BB; outlook Negative
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Lowe's (LOW) PT Lowered to $275 at Guggenheim
- Okta, Inc (OKTA) PT Raised to $170 at Cantor Fitzgerald Ahead of Q2 Results
- 'We expect salesforce.com (CRM) to capture a meaningful share of next-gen agentic workflows': Cantor
Create E-mail Alert Related Categories
Credit RatingsRelated Entities
Standard & Poor'sSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
